Flagship Biosciences expands operations to meet tremendous industry growth demands

Escalated demand for Flagship’s tissue analysis capabilities are being driven by proven success. Westminster, CO – March 15, 2016 – Flagship’s track record of success has increased the adoption of the company’s technology and the demand for their specialty tissue image analysis solutions. To meet this demand, the company has expanded its facilities and staff, […]

Read More

Flagship Biosciences and Beaufort, LLC partner to provide Clinical Trial Services for the Pharmaceutical Industry

Flagship Biosciences establishes partnership with Beaufort, an industry-leading CRO, to provide a full range of clinical trial services to advance initiatives that bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – February 2, 2016 – Flagship Biosciences, Inc. announces that Beaufort, LLC., www.beaufortcro.com, an industry leading diagnostic-CRO with extensive experience […]

Read More

Flagship Creates Clinical Trials and Regulatory Affairs Group

Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – January 19th, 2016 – Flagship Biosciences has created a Clinical Trials and Regulatory Affairs group and partners […]

Read More

Quality Management System for the development of Medical Device Software

Flagship Biosciences establishes a Quality Management System (QMS) for the development of medical device software to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – October 27, 2015 – Flagship Biosciences’ Software Development Department has established a Quality Management System (QMS) for the development of medical device software in compliance […]

Read More

Flagship launches new website to highlight areas of clinical focus

Denver, CO – Oct 20, 2015 – Flagship Biosciences, the largest tissue image analysis provider for the drug development industry, is pleased to announce a website redesign, which highlights our advanced technology and clinical readiness needed to support image analysis based companion diagnostic strategies for the pharmaceutical industry. Flagship’s growth has been accelerated by the […]

Read More

Dr. Dan Rudmann Joins Flagship Biosciences as VP of Program Development

Westminster, CO – Sept 16, 2015 – Flagship Biosciences continues to expand its leadership position in pathology-focused tissue image analysis with the addition of Dr. Dan Rudmann as Vice President of Program Development. Dr. Rudmann comes to Flagship with more than 18 years of experience in drug development and pathology, most recently as Global Head […]

Read More

Datacolor and Flagship Biosciences to Integrate CHROMACAL Color Calibration into TALIS Digital Imaging Platform

Lawrenceville, NJ – September 9, 2015 – Datacolor® and Flagship Biosciences, Inc. (Westminster, CO) have announced a new collaboration to integrate Datacolor CHROMACAL™ color calibration technology into Flagship’s proprietary digital imaging platform TALIS™ (Tissue Analysis Laboratory Information System). The collaboration is significant because it combines the technologies of two industry leaders to establish a new […]

Read More

Dr. Cris Luengo joins Flagship as Director of Image Analysis

Top image analysis expert Dr. Cris Luengo joins Flagship Biosciences as Director of Image Analysis Westminster, CO – July 20, 2015 – – Flagship Biosciences continues to expand its leadership position in tissue image analysis with the addition of Dr. Cris Luengo as Director of Image Analysis. Dr. Luengo is an internationally recognized expert in […]

Read More

Flagship Biosciences presents tumor immunology research at AACR meeting

Flagship Biosciences gives three posters and one oral presentation at AACR meeting Westminster, CO – April 20, 2015 – Flagship Biosciences will be presenting its industry-leading research in tissue image analysis and tumor immunology at the American Association of Cancer Research (AACR) annual meeting in Philadelphia, Pennsylvania. Flagship’s technology is developed in partnership with pharmaceutical […]

Read More

Flagship Biosciences customizes assay development and tissue image analysis for Advanced Cell Diagnostics RNAscope platform

Flagship Biosciences and Advanced Cell Diagnostics collaborate to develop quantitative RNAscope® assays for pharmaceutical clinical trials in the CLIA environment Westminster, CO – April 15, 2015 – Flagship Biosciences, the leading service provider of tissue image analysis solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope® RNA […]

Read More